Court denies Myriad motion to block rival genetic tests

[riky]

Court denies Myriad motion to block rival genetic tests

(Reuters) - Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company. Myriad's shares fell 12 percent before the bell on Tuesday. Myriad's problems started last June when the U.S. Supreme Court ruled that the company could not patent naturally occurring human genes, curbing the company's monopoly over a type of gene-based cancer testing. That ruling allowed other test makers, including Quest Diagnostics Inc and privately held Ambry, to develop and market the so-called BRCA tests.

Source: You are not allowed to view links. Register or Login